BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 22652735)

  • 1. Role of peritoneal dialysis as a chronic renal replacement therapy in cardiorenal patients.
    Pego C; Rodrigues A; Ronco C
    Contrib Nephrol; 2012; 178():182-188. PubMed ID: 22652735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The peritoneal ultrafiltration in patients with cardio-renal disease].
    Corciulo R; Corciulo S
    G Ital Nefrol; 2017 Mar; 34(Suppl 69):86-103. PubMed ID: 28682031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peritoneal Dialysis for Chronic Congestive Heart Failure.
    François K; Ronco C; Bargman JM
    Blood Purif; 2015; 40(1):45-52. PubMed ID: 26111872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tidal peritoneal dialysis versus ultrafiltration in type 1 cardiorenal syndrome: A prospective randomized study.
    Al-Hwiesh AK; Abdul-Rahman IS; Al-Audah N; Al-Hwiesh A; Al-Harbi M; Taha A; Al-Shahri A; Ghazal S; Amir R; Al-Audah N; Mansour H; El-Mansouri M; El-Salamony TS; Nasr El-Din MA; Noor A; Al-Elq Z; Alzahir ZH; Alzawad NA
    Int J Artif Organs; 2019 Dec; 42(12):684-694. PubMed ID: 31303099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peritoneal dialysis in patients with heart failure.
    Van Der Sande FM; Cnossen TT; Cornelis T; Konings CJ; Kooman JP; Leunissen KM
    Minerva Urol Nefrol; 2012 Sep; 64(3):163-72. PubMed ID: 22971681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ultrafiltration therapy for cardiorenal syndrome: physiologic basis and contemporary options.
    Ross EA; Kazory A
    Blood Purif; 2012; 34(2):149-57. PubMed ID: 23095414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Usefulness of Peritoneal Ultrafiltration in Patients with Diuretic Resistant Heart Failure without End-Stage Renal Disease.
    Sahin E; Gökçay Bek S; Eren N; Karauzum I; Ergul M; Yildiz N; Sahin T; Dervisoglu E; Kalender B
    Cardiorenal Med; 2020; 10(6):429-439. PubMed ID: 33022682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peritoneal Dialysis for the Treatment of Cardiorenal Syndrome Type 1: A Prospective Brazilian Study.
    Ponce D; Góes C; Oliveira M; Balbi A
    Perit Dial Int; 2017; 37(5):578-583. PubMed ID: 28931700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Continuous Veno-Venous Hemofiltration Improves Survival of Patients With Congestive Heart Failure and Cardiorenal Syndrome Compared to Slow Continuous Ultrafiltration.
    Premuzic V; Basic-Jukic N; Jelakovic B; Kes P
    Ther Apher Dial; 2017 Jun; 21(3):279-286. PubMed ID: 28403554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Customization of Peritoneal Dialysis in Cardiorenal Syndrome by Optimization of Sodium Extraction.
    Kazory A; Koratala A; Ronco C
    Cardiorenal Med; 2019; 9(2):117-124. PubMed ID: 30726844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peritoneal dialysis for chronic cardiorenal syndrome: Lessons learned from ultrafiltration trials.
    Kazory A
    World J Cardiol; 2015 Jul; 7(7):392-6. PubMed ID: 26225199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of early and sufficient isolated venovenous ultrafiltration in heart failure patients with pulmonary and systemic congestion.
    Costanzo MR; Chawla LS; Tumlin JA; Herzog CA; McCullough PA; Kellum JA; Ronco C
    Rev Cardiovasc Med; 2013; 14(2-4):e123-33. PubMed ID: 24448253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Acute cardiorenal syndrome: recovery of renal function after renal replacement therapy].
    Lubas A; Próchnicka A; Syta U; Niemczyk S
    Kardiol Pol; 2013; 71(1):61-2. PubMed ID: 23348536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonuremic indication for peritoneal dialysis for refractory heart failure in cardiorenal syndrome type II: review and perspective.
    Nakayama M
    Perit Dial Int; 2013; 33(1):8-14. PubMed ID: 23349193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes after Acute Peritoneal Dialysis for Critical Cardiorenal Syndrome Type 1.
    Parapiboon W; Kingjun T; Wongluechai L; Leawnoraset W
    Cardiorenal Med; 2021; 11(4):184-192. PubMed ID: 34315169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Visions in a Crystal Ball: The Future of Peritoneal Dialysis.
    Bargman JM; Girsberger M
    Blood Purif; 2018; 45(1-3):218-223. PubMed ID: 29478058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of ultrafiltration and diuretic therapies on oxidative stress markers in patients with cardio-renal syndrome.
    Sav T; Cecen F; Albayrak ES
    Minerva Urol Nefrol; 2017 Aug; 69(4):400-407. PubMed ID: 27097156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal replacement therapy after repair of congenital heart disease in children. A comparison of hemofiltration and peritoneal dialysis.
    Fleming F; Bohn D; Edwards H; Cox P; Geary D; McCrindle BW; Williams WG
    J Thorac Cardiovasc Surg; 1995 Feb; 109(2):322-31. PubMed ID: 7853885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cardiorenal syndrome: limits of heart failure therapy].
    Großekettler L; Schmack B; Schwenger V
    Herz; 2013 Sep; 38(6):569-77. PubMed ID: 23740085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parameters associated with therapeutic response using peritoneal dialysis for therapy refractory heart failure and congestive right ventricular dysfunction.
    Pavo N; Yarragudi R; Puttinger H; Arfsten H; Strunk G; Bojic A; Hülsmann M; Vychytil A
    PLoS One; 2018; 13(11):e0206830. PubMed ID: 30452453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.